New Form of Oxbryta Suitable for Children Now Available in US

New Form of Oxbryta Suitable for Children Now Available in US

315981

New Form of Oxbryta Suitable for Children Now Available in US

A new formulation of Oxbryta (voxelotor) that is suitable for treating children as young as 4 is now available in the U.S. at specialty pharmacies. Late last year, the U.S. Food and Drug Administration (FDA) expanded the approval of Oxbryta to treat children with sickle cell disease (SCD) as young as 4 — the therapy had previously been available as 500 milligram (mg) tablets and approved for use in patients ages 12 and older. At the…

You must be logged in to read/download the full post.